Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (1528)	12/10/2001 1:55:42 PM
From: tuck	Read Replies (1) \| Respond to of 1728

Thanks, a small victory, since my adversaries were Fools. The top of this article mentions work by AFFX and Johns Hopkins folks that seems important but I do not recall seeing a PR about it -- at least not posted here. GeneChips as gene sequencers? Should ABI be looking over its shoulder? Whattya think, V1? I've been expecting some kind of pullback, and was hoping to get Trickle back in for the long haul in the high 20s (that and EBIO are two reasons Trickle is sitting on bunch of cash right now, waiting to buy -- much of it courtesy of AFFX) . . . dddmag.com Cheers, Tuck